A respiratory syncytial virus is a common pneumovirus that causes seasonal lung and respiratory tract infections across the globe.
14 February 2019 Comment
11 February 2019 News
Microbial therapies developer Finch Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational CP101 drug to treat recurrent Clostridium difficile (C. difficile)...
5 February 2019 Comment
GlobalData believes these results should be treated with cautious optimism.
31 January 2019 News
UK Health and Social Care Secretary Matt Hancock has set a goal to end new HIV transmissions in the country by 2030 through improved prevention, detection and treatment of the...
24 January 2019 News
The UK Government has set out a plan to fight antimicrobial resistance (AMR) in the country by 2040, with an aim to cut down antibiotics use by 15% over the...
15 January 2019 News
Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment of viral diseases such as hepatitis B in Greater China.
14 January 2019 News
An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to...
26 December 2018 Comment
GlobalData believes that mRNA vaccines may be more favourable to DNA vaccines because they do not have to overcome the nuclear membrane before transcription.
19 December 2018 Analysis
Find out about the foundation for the first drugs using microbiome bacteria in the latest issue of Pharma Technology Focus
In this issue: A new class of cancer combo treatments, antidepressants in the environment, microbiome-based drug development, and more.